Detalhe da pesquisa
1.
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study.
Ann Oncol
; 32(5): 600-608, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539945
2.
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma.
Ann Oncol
; 32(2): 250-260, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188873
3.
BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
Br J Surg
; 106(9): 1237-1247, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31183866
4.
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Ann Oncol
; 29(5): 1211-1219, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438522
5.
Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial.
Ann Oncol
; 29(4): 931-937, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365058
6.
DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer.
Br J Cancer
; 115(10): 1245-1252, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27755532
7.
FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort.
Ann Surg Oncol
; 22(1): 295-301, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037971
8.
Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: A retrospective multicenter study.
Dig Liver Dis
; 56(3): 514-521, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718226
9.
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.
Ann Oncol
; 24(2): 412-419, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041588
10.
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial.
Ann Oncol
; 24(8): 2057-61, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23676420
11.
Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physicians.
J Eur Acad Dermatol Venereol
; 27(4): 419-29, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22211860
12.
Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma.
Clin Res Hepatol Gastroenterol
; 47(4): 102108, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878461
13.
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
Ann Oncol
; 23(9): 2327-2335, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22377565
14.
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.
Ann Oncol
; 23(3): 570-576, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810728
15.
Salvage colectomy for endoscopically removed malignant colon polyps: is it possible to determine the optimal number of lymph nodes that need to be harvested?
Colorectal Dis
; 14(1): 79-86, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22145739
16.
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.
Support Care Cancer
; 20(5): 909-21, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22361824
17.
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.
Support Care Cancer
; 20(7): 1395-404, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22539049
18.
%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology.
Comput Methods Programs Biomed
; 214: 106537, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879326
19.
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer.
Transl Oncol
; 16: 101315, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906890
20.
Prognosis and predictive value of KIT exon 11 deletion in GISTs.
Br J Cancer
; 101(1): 7-11, 2009 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19536093